期刊文献+

奥曲肽通过G_0/G_1期阻滞抑制胆管癌细胞的增殖 被引量:3

Cytostatic effect of octreotide on human cholangiocarcinoma cell proliferation via a G_0/G_1 cycle block
下载PDF
导出
摘要 为观察四种胆管癌细胞系 (RBE、NEC、QBC939、SSP 2 5 )是否能够表达生长抑素受体 (SSTR) ,以及八肽生长抑素类似物奥曲肽 (OCT)对胆管癌细胞的抑制作用 ,采用逆转录 聚合酶链反应方法检测四种细胞系 2 ,3型SSTR的表达 ;四氮唑蓝法检测不同浓度OCT (10、 1、 0 1、 0 0 1和 0 0 0 1mg L)在体外对胆管癌细胞增殖的影响。并应用碘化丙啶 (PI)及AnnexinV PI染色后于流式细胞仪检测经OCT作用后胆管癌细胞的细胞周期和凋亡情况。结果显示四种胆管癌细胞系均可以表达SSTR2 mRNA ,但未检测到SSTR3mRNA的表达。体外 10、 1和0 1mg LOCT明显抑制四种胆管癌细胞的增殖 (与各自对照组相比 ,P <0 0 5 ) ;1mg LOCT作用 4 8h后流式细胞分析表现为G0 G1 期细胞增加 ,S期和G2 M细胞减少 (与各自对照组相比 ,P <0 0 1) ,但没有明显凋亡发生。从而证明OCT抑制胆管癌细胞增殖的机制主要与引起细胞周期阻滞有关 ,而不是促进凋亡。对于表达生长抑素受体的胆管癌 。 To observe the expression of somatostatin receptor(SSTR) in four cholangiocarcinoma cell lines(RBE, NEC, QBC 939 , SSP 25), and to investigate the inhibitory effects of somatostatin analog octreotide (OCT) on the proliferation of them, Type 2 and 3 SSTR mRNA in cholangiocarcinoma cell lines were detected by reverse transcriptase polymerase chain reaction technique (RT PCR).The effects of various doses (10?1?0.1?0.01 and 0.001mg/L) of OCT on the proliferation of above cholangiocarcinoma cell lines were evaluated by MTT assays with serum free medium as control. The cell cycle and apoptosis of the cells with and without OCT treatment were analyzed in flow cytometry with propidium iodide (PI) staining and FITC conjugated Annexin V PI double staining. Not only SSTR 3 but also SSTR 2 mRNA were be detected in all cholangiocarcinoma cell lines. OCT (10, 1 and 0.1mg/L) significantly inhibited the proliferation of four cholangiocarcinoma cell lines in vitro (P values were all less than 0.05 when compared with control). After 48h of exposure to 1mg/L OCT, flow cytometric analysis demonstrated increased cell number of G 0/G 1 phase accompanied with decreased cell number of G 2/M and S phase (P values were all less than 0.01 when compared with control), while apotosis was not seen in all samples. The results proved that OCT inhibited proliferation of cholangiocarcinoma cells, this effect seems mainly due to cytostatic effect rather than promoting the way of apoptosis. Thereby, OCT may posess the perspectives in the adjuvant therapy for SSTR positive biliary tract malignancies.
出处 《基础医学与临床》 CSCD 北大核心 2002年第3期251-254,共4页 Basic and Clinical Medicine
关键词 奥曲肽 G0/G1期阻滞 胆管癌 生长抑素受体 细胞增殖 药物疗法 治疗 cholangiocarcinoma somatostatin receptor chemotherapy
  • 相关文献

参考文献6

  • 1[1]Kéri GY, érchegyi J, Horváth A, et al. A tumor-selective somatostatin analog(TT-232) with strong in vitro and in vivo antitumor activity [J]. Proc Natl Acad Sci, 1996,93:12513-12518.
  • 2[2]Kubota A, Yamada Y, Kagimoto S, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors [J]. J Clin Invest, 1994,93(3):1321-1325.
  • 3[3]Reubi JC, Schacr JC, Waser B, et al. Expression and localization of somatostin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization [J]. Cancer Res, 1994,54:3455-3459.
  • 4[4]Cattaneo MG, Amoroso D, Gussoni G, et al. A somatostatin analogue inhibits MAP kinse activation and cell proliferation in human neuroblastoma and in human small cell lung crcinoma cell lines [J]. FEBS Lett, 1996,397:164-168.
  • 5[5]Sharma K, Patel YC, Srikant CB. Subtype selective induction of p53-dependent apoptosis but not cell cycle arrest by human somatostatin receptor 3 [J]. Mol Endocrinol, 1996,10:1688-1696.
  • 6[6]Ambler GR, Butler AA, Padmanabhan J, et al. The effects of octreotide on GH receptor and IGF-I expression in the GH-deficient rat [J]. J Endocrinol, 1996,149:223-231.

同被引文献24

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部